By Daniel Chen, Beauty Editor · Reviewed by SKINDIRECTNEWS Editorial · 5 min read
After 20 years of watching his patients, and eventually his own wife fail with creams, hydroquinone, and lasers, a Seoul dermatologist quietly built something different. And women are finally seeing melasma fade.

Dr. Jihoon Kim had been treating melasma at his Seoul clinic for two decades. He'd prescribed every cream on the market.
Watched women return month after month, spending thousands, only to see the same stubborn pigmentation staring back at them in the mirror.
Then his wife turned 48. And the melasma she'd carried since her second pregnancy started to spread across her cheekbones.
Foundation stopped covering it.
She began avoiding photos. Avoiding mirrors.
"I had every prescription in my clinic," Dr. Kim said.
"And nothing I gave her worked. That was the moment I realised the problem wasn't the ingredients. It was the delivery."
Melasma lives in the deeper pigment layers of the skin, layers a topical serum has almost no chance of reaching.
Every cream he'd prescribed was working on the surface. The pigment was underneath.
That's the problem he set out to solve.

Working with a K-beauty formulation lab in late 2025, Dr. Kim began re-engineering the hydrogel patch — the same delivery format Korea had already perfected for under-eye brightening, into something that could carry active brighteners deep into the pigment layer instead of sitting on top of it.
The result was Glowr Glutathione Dark Spot Serum Patch 7, a translucent, butter-yellow hydrogel patch loaded with three of the most clinically-backed brightening actives in modern dermatology:
Glutathione, Niacinamide, and NAG (Acetyl Glucosamine).
Unlike a serum, the patch adheres to the skin and slowly releases its actives over 30 minutes to 2 hours, turning transparent as it absorbs.
His wife was the first person to try it. Within days, the shadow above her lip just so subtedly started to lift. Within weeks, she was going out without foundation for the first time in years.
Then he gave it to his patients. And the same thing happened.

Most topical brighteners fail for the same reason. The moment a serum hits the skin, it begins to evaporate.
Whatever active it was carrying — Vitamin C, arbutin, kojic acid — is left sitting on the surface, where it oxidises in contact with air and light within minutes.
Very little of it ever reaches the melanocytes producing the pigment underneath. A hydrogel patch works differently.
It creates a sealed, hydrated environment against the skin, and the actives are released continuously, not in a 30-second window, but over hours.
The patch physically holds the ingredients in contact with the skin long enough for them to penetrate all three pigmentation layers, where melasma actually lives.
"It's essentially a slow-drip IV for your skin's pigment cells," Dr. Kim explained.
"You can't spray a wall with paint and expect it to soak through. You have to press it in and hold it there."
That single design change is what allowed his formulation to do what topical serums couldn't.

Dr. Kim's formulation stacks three well-studied brighteners, each targeting a different stage of pigment formation:
Glutathione — suppresses new pigment forming at the root by inhibiting tyrosinase, the enzyme responsible for melanin production.
Clinically shown to be 2.5x more effective than Vitamin C on deep hyperpigmentation.
Niacinamide — blocks melanin from transferring to the surface of the skin, preventing new spots from becoming visible.
NAG (Acetyl Glucosamine) — works on the surface layer to fade existing dark spots. Clinical studies show NAG is significantly more effective when paired with niacinamide than either used alone..
The three ingredients work in sequence: prevent, block, fade.
After 7 days of twice-daily use, the controlled study recorded the following measured improvements:
- 20.38% visual reduction in surface dark spots
- 2.5x more effective than Vitamin C on deep pigmentation
- 28.48% reduction in redness after a single application
Participants with long-standing melasma — including women who'd carried post-pregnancy melasma for 5+ years and had tried everything from hydroquinone to laser, reported visible fading within the first 7-10 days.
Several described it as the first product in years that had done anything at all.

"I got melasma after my second pregnancy and it's been 6 years of trying everything — Vitamin C, arbutin, even hydroquinone that my derm prescribed. Nothing worked. I saw a difference in my mustache shadow after 5 days with these." — Maria, 34
"I have super sensitive skin and I'd basically given up on anything active. The patches don't sting, don't burn, and my cheek pigmentation is genuinely fading. My husband noticed before I did." — Jenna, 42
"51 and I have sun damage from decades of Australian summers. I'm 10 days in and the spots on my cheekbones have visibly lightened. I'm not saying it's a miracle but for the first time in years I'm going out without foundation." — Lauren, 51
Glowr sells the patches directly to consumers, no pharmacy markup, no in-clinic fees.
Each jar contains 30 patches, and because each patch splits four ways (into hearts for targeted spots, or halves for broader areas like under the eyes), a single jar delivers 120 individual applications.
Current launch pricing is $35 for a starter jar, or their Buy 2 Get 1 Free bundle for $70 with free shipping and a complimentary jade face roller, the option most first-time customers choose.
Every order is backed by a 60-day money-back guarantee. If you don't see visible fading, you get a full refund.
*13% Stock Availability Left. Get It While You Still Can
Purrify Max is a refined edition of the Original Stainless Steel Fountain. Produced in very limited numbers, it’s designed for cat parents who want the absolute best. Once this run sells out, it won’t be back. 👇




© 2026 (Glowr). All Rights Reserved. Privacy Policy Terms of Use
Advertisement — This article is a paid partnership between Health Insider and Glowr. Individual results may vary. Statements have not been evaluated by the FDA. Not intended to diagnose, treat, cure, or prevent any disease.